Histidine-rich glycoprotein exerts antibacterial activity

FEBS Journal

Volumn 274, Issue 2, 2007, Pages 377-389

  Rydengård, Victoria ^a   Olsson, Anna Karin ^b   Mörgelin, Matthias ^a   Schmidtchen, Artur ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibacterial; Heparin; Histidine rich glycoprotein; pH; Zinc

Indexed keywords

HEPARIN BINDING PROTEIN; HISTIDINE; ZINC;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOLYSIS; CONSENSUS SEQUENCE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENTEROCOCCUS FAECALIS; FLUORESCENCE MICROSCOPY; HUMAN; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ENTEROCOCCUS FAECALIS; HEPARIN; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; ZINC;

ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 33845970531     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05586.x     Document Type: Article

References (45)

1. Nair PS & Robinson WE (1999) Purification and characterization of a histidine-rich glycoprotein that binds cadmium from the blood plasma of the bivalve Mytilus edulis. Arch Biochem Biophys 366, 8-14.
2. Shigekiyo T, Yoshida H, Matsumoto K, Azuma H, Wakabayashi S, Saito S, Fujikawa K & Koide T (1998) HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency. Blood 91, 128-133.
3. Leung LL, Harpel PC, Nachman RL & Rabellino EM (1983) Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 62, 1016-1021.
4. Jones AL, Hulett MD & Parish CR (2005) Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol 83, 106-118.
5. 2+-dependent manner. J Biol Chem 281, 10298-10304.
6. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
7. Schröder JM & Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31, 645-651.
8. Boman HG (2000) Innate immunity and the normal microflora. Immunol Rev 173, 5-16.
9. Zasloff M (1992) Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 4, 3-7.
10. Gallo RL, Murakami M, Ohtake T & Zaiou M (2002) Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110, 823-831.
11. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukocyt Biol 75, 39-48.
12. Andersson E, Rydengård V, Sonesson A, Mörgelin M, Björck L & Schmidtchen A (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271, 1219-1226.
13. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Malmsten M, Björck L & Schmidtchen A (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci USA 101, 16879-16884.
14. Nordahl EA, Rydengård V, Mörgelin M & Schmidtchen A (2005) Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 280, 34832-34839.
15. Cardin AD & Weintraub HJ (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32.
16. Ringstad L, Schmidtchen A & Malmsten M (2006) Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir 22, 5042-5050.
17. Rydengård V, Andersson Nordahl E & Schmidtchen A (2006) Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis. Febs J 273, 2399-2406.
18. Aarestrup FM & Hasman H (2004) Susceptibility of different bacterial species isolated from food animals to copper sulphate, zinc chloride and antimicrobial substances used for disinfection. Vet Microbiol 100, 83-89.
19. Boman HG, Agerberth B & Boman A (1993) Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61, 2978-2984.
20. Den Hertog AL, Wong Fong Sang HW, Kraayenhof R, Bolscher JG, Van't Hof W, Veerman EC & Nieuw Amerongen AV (2004) Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem J 379, 665-672.
21. Borza DB, Tatum FM & Morgan WT (1996) Domain structure and conformation of histidine-proline-rich glycoprotein. Biochemistry 35, 1925-1934.
22. Lee IH, Cho Y & Lehrer RI (1997) Effects of pH and salinity on the antimicrobial properties of clavanins. Infect Immun 65, 2898-2903.
23. Nishikawa M & Ogawa K (2004) Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense. Antimicrob Agents Chemother 48, 229-235.
24. Bosshart H & Heinzelmann M (2003) Endotoxin-neutralizing effects of histidine-rich peptides. FEBS Lett 553, 135-140.
25. Levy O (2000) Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96, 2664-2672.
26. Elsbach P & Weiss J (1998) Role of the bactericidal/permeability- increasing protein in host defence. Curr Opin Immunol 10, 45-49.
27. Gifford JL, Hunter HN & Vogel HJ (2005) Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 62, 2588-2598.
28. Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, Oellig C, Björk I & Claesson-Welsh L (2004) A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Cancer Res 64, 599-605.
29. Mori S, Shinohata R, Renbutsu M, Takahashi HK, Fang YI, Yamaoka K, Okamoto M, Yamamoto I & Nishibori M (2003) Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin. Cell Tissue Res 312, 353-359.
30. Guan X, Juarez JC, Qi X, Shipulina NV, Shaw DE, Morgan WT, McCrae KR, Mazar AP & Donate F (2004) Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb Haemost 92, 403-412.
31. Borza DB & Morgan WT (1998) Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals. J Biol Chem 273, 5493-5499.
32. Wright J, Schwartz JH, Olson R, Kosowsky JM & Tauber AI (1986) Proton secretion by the sodium/hydrogen ion antiporter in the human neutrophil. J Clin Invest 77, 782-788.
33. Gorodetsky R, Mou X, Blankenfeld A & Marx G (1993) Platelet multielemental composition, lability, and subcellular localization. Am J Hematol 42, 278-283.
34. Michaelsson G, Ljunghall K & Danielson BG (1980) Zinc in epidermis and dermis in healthy subjects. Acta Derm Venereol 60, 295-299.
35. Brown KL & Hancock RE (2006) Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 18, 24-30.
36. Gabay JE, Scott RW, Campanelli D, Griffith J, Wilde C, Marra MN, Seeger M & Nathan CF (1989) Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 86, 5610-5614.
37. Wang Y, Agerberth B, Lothgren A, Almstedt A & Johansson J (1998) Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 273, 33115-33118.
38. Leung LL (1986) Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 77, 1305-1311.
39. Tsuchida-Straeten N, Ensslen S, Schafer C, Woltje M, Denecke B, Moser M, Graber S, Wakabayashi S, Koide T & Jahnen-Dechent W (2005) Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost 3, 865-872.
40. Mori S, Takahashi HK, Yamaoka K, Okamoto M & Nishibori M (2003) High affinity binding of serum histidine-rich glycoprotein to nickel-nitrilotriacetic acid: the application to microquantification. Life Sci 73, 93-102.
41. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
42. Vernersson M, Ledin A, Johansson J & Hellman L (2002) Generation of therapeutic antibody responses against IgE through vaccination. FASEB J 16, 875-877.
43. Laemmli UK, Beguin F & Gujer-Kellenberger G (1970) A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol 47, 69-85.
44. Cheng F, Yoshida K, Heinegard D & Fransson LA (1992) A new method for sequence analysis of glycosaminoglycans from heavily substituted proteoglycans reveals non-random positioning of 4- and 6-O-sulphated N-acetylgalactosamine in aggrecan-derived chondroitin sulphate. Glycobiology 2, 553-561.
45. Schmidtchen A, Frick I-M & Björck L (2001) Dermatan sulfate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 39, 708-713.